Alnylam Gets VIP Status as the FDA Slaps Breakthrough Tag on Patisiran Post author:Sam Post published:November 19, 2017 Post category:BioPharma The company is weeks away from completing its rolling NDA for Patisiran. Source: BioSpace You Might Also Like BioSig Technologies Release: Company Issues Shareholder Letter January 19, 2017 Theranos Serves as a Cautionary Tale for Biotech Funding March 15, 2018 Johnson & Johnson Hosts 'Shark-Tank'-Like Competition and Crowned This Biotech Startup as Its Winner April 18, 2017
Johnson & Johnson Hosts 'Shark-Tank'-Like Competition and Crowned This Biotech Startup as Its Winner April 18, 2017
